A study of BPS-804 for the treatmetn of osteogenesis imperfecta in paediatric patients.

Trial Profile

A study of BPS-804 for the treatmetn of osteogenesis imperfecta in paediatric patients.

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs BPS 804 (Primary)
  • Indications Osteogenesis imperfecta
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Aug 2017 According to a Mereo BioPharma media release, the company intends to begin this study towards the end of 2017.
    • 10 May 2017 New trial record
    • 04 May 2017 According to a Mereo BioPharma media release, the company intends to begin this study in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top